Search CatalystAlert
Search for companies, drugs, and catalysts
Search CatalystAlert
Search for companies, drugs, and catalysts
Search for companies, drugs, and catalysts
Search for companies, drugs, and catalysts
Drugs in Pipeline
10
Phase 3 Programs
6
Upcoming Catalysts
2
Next Catalyst
Mar 1, 2026
10w| Drug Name | Phase |
|---|---|
Mesenchymal Stem Cells | Phase 3 |
CU-20101 treatment for Moderate to Severe Glabellar Striae | Phase 3 |
Lidocaine tetracaine cream | Phase 3 |
5 mg BGM0504 injection | Phase 3 |
CU-40102 Spray | Phase 3 |
Guideline-directed medical therapy (GDMT) for heart failure | Phase 3 |
D3S-002 | Phase 2 |
D3S-001 | Phase 2 |
CU-20401 | Phase 2 |
Subcutaneous injection of CU-20401 | Phase 2 |
2 upcoming, 0 past
Primary completion for CU-20101 treatment for Moderate to Severe Glabellar Striae trial (NCT06585696) in Glabellar Frown Lines
SourcePrimary completion for Mesenchymal Stem Cells trial (NCT06570291) in Knee Osteoarthritis
Source